5-lipoxygenase-activating protein (FLAP) inhibitors

Details for Australian Patent Application No. 2006311973 (hide)

Owner Amira Pharmaceuticals, Inc.

Inventors Moran, Mark; Arruda, Jeannie M.; Stearns, Brian Andrew; Hutchinson, John H.; Zunic, Jasmine Eleanor; Li, Yiwei; Evans, Jillian F.; Haddach, Mustapha; Roppe, Jeffrey Roger; Stock, Nicholas Simon; Prasit, Petpiboon Peppi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006311973

PCT Pub. Number WO2007/056021

Priority 60/747,174 12.05.06 US; 60/734,030 04.11.05 US; 60/823,344 23.08.06 US; 11/553, 946 27.10.06 US

Filing date 30 October 2006

Wipo publication date 18 May 2007

Acceptance publication date 2 December 2010

International Classifications

C07D 209/00 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/415 (2006.01) - 1,2-Diazoles

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/056021 Priority application(s): WO2007/056021

2 December 2010 Application Accepted

  Published as AU-B-2006311973

31 March 2011 Standard Patent Sealed

3 November 2011 Assignment Registered

  Amira Pharmaceuticals, Inc. The patent has been assigned to Panmira Pharmaceuticals, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311978-Silicone gel-forming compositions and hysteretic silicone gel and device comprising the gel

2006311966-Method evolved for recognition and testing of age related macular degeneration (MERT-ARMD)